Lv21
126 积分 2024-04-25 加入
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
3小时前
已完结
When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program
25天前
已完结
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee
27天前
已完结
Generation of mice with a conditional allele for the p75NTR neurotrophin receptor gene
28天前
已完结
Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial
28天前
已完结
PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response
1个月前
已完结
PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders
1个月前
已完结
Structure-based design of non-hypertrophic apelin receptor modulator
1个月前
已完结
Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension
1个月前
已完结
Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone
1个月前
已完结
皖公网安备34019202002308
